| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.6M | $15.4M | $30.6M |
| YoY Revenue Growth % | -70.1% | -49.5% | — |
| Gross Profit | $353.0K | $446.0K | — |
| Gross Margin % | 7.7% | 2.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$2.0M | -$3.8M | -$6.0M |
| Operating Margin % | -42.3% | -24.3% | -19.7% |
| Net Income (GAAP) | -$1.8M | -$3.8M | -$6.0M |
| EBITDA (Normalized) | -$1.9M | -$3.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$929.0K | -$2.1M | -$2.0M |
| Capital Expenditures (CapEx) | $65.0K | $3.0K | — |
| Free Cash Flow (FCF) | -$994.0K | -$2.1M | -$2.0M |
| FCF Margin % | -21.5% | -13.3% | -6.6% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $970.0K | $812.0K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $4.3M | $3.7M | — |